About Flexion Therapeutics
Flexion Therapeutics is a company based in Woburn (United States) founded in 2007 was acquired by Pacira in October 2021. Flexion Therapeutics has raised $62 million across 4 funding rounds from investors including Pfizer, Pacira and 5AM Ventures. The company has 692 employees as of December 31, 2022. Flexion Therapeutics operates in a competitive market with competitors including Formation Bio, Eliem Therapeutics, Zogenix, Heron Therapeutics and Ethypharm, among others.
- Headquarter Woburn, United States
- Employees 692 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$85.55 M (USD)17as on Dec 31, 2020
-
Net Profit
-$113.71 M (USD)24as on Dec 31, 2020
-
EBITDA
-$93.02 M (USD)32as on Dec 31, 2020
-
Total Equity Funding
$62 M (USD)
in 4 rounds
-
Latest Funding Round
$175 M (USD), Post-IPO
May 01, 2017
-
Investors
Pfizer
& 6 more
-
Employee Count
692
as on Dec 31, 2022
-
Acquired by
Pacira
(Oct 11, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Flexion Therapeutics
Unlock access to complete
Unlock access to complete
Leadership Team
105 people
Account Team
28 people
Software Development Team
20 people
Sales and Marketing
18 people
Senior Team
14 people
Product Management Team
13 people
Finance and Accounting
11 people
Operations Team
11 people
Unlock access to complete
Funding Insights of Flexion Therapeutics
Flexion Therapeutics has successfully raised a total of $62M across 4 strategic funding rounds. The most recent funding activity was a Post-IPO round of $175 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Flexion Therapeutics
Flexion Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Pfizer, Pacira and 5AM Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed incubator focused on the healthcare startups
|
Locked | Locked | Locked | |
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Locked | Locked | Locked | |
|
Private equity and venture capital fund focused on the healthcare sector
|
Locked | Locked | Locked |
Investor details for Flexion Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Flexion Therapeutics
Investment portfolio details for Flexion Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Flexion Therapeutics
Detailed financials for Flexion Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Flexion Therapeutics Comparisons
Peer comparison for Flexion Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Flexion Therapeutics
Flexion Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Formation Bio, Eliem Therapeutics, Zogenix, Heron Therapeutics and Ethypharm, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
Develops antibody-based treatments for autoimmune and inflammatory disorders.
|
|
| Locked | Locked | Locked |
Drug delivery systems for CNS disorders and pain are developed.
|
|
| Locked | Locked | Locked |
Reformulated injectables for chemotherapy side effects and pain are developed.
|
|
| Locked | Locked | Locked |
Therapies for pain and addiction treatment are developed.
|
Detailed competitors of Flexion Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Flexion Therapeutics
Complete news archive for Flexion Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Flexion Therapeutics
Flexion Therapeutics was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Flexion Therapeutics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Flexion Therapeutics is a funded company, having raised a total of $62M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Flexion Therapeutics is 692.
Annual revenue of Flexion Therapeutics is $85.55M as on Dec 31, 2020.
Developer of therapies for the treatment of musculoskeletal disorders. The company is currently advancing a portfolio of injectable drug candidates that have the potential to provide better and more persistent analgesia compared with existing therapies. Their lead program, FX006, is an intra-articular sustained-release steroid injectable for patients with moderate to severe osteoarthritis (OA) pain. They also have two additional product candidates FX007, a locally administered TrkA receptor antagonist for post-operative pain, and FX005, an intra-articular, sustained-release p38 MAP kinase inhibitor for end-stage OA patients.
Flexion Therapeutics's top competitors include Formation Bio, Cara Therapeutics and PainReform.
Flexion Therapeutics has 7 investors. Key investors include Pfizer, Pacira, 5AM Ventures, Versant Ventures, and Novo Holdings.